Thor Medical ASA (FRA:8NN)

Germany flag Germany · Delayed Price · Currency is EUR
0.3575
+0.0040 (1.13%)
At close: Dec 19, 2025
65.51%
Market Cap134.43M
Revenue (ttm)8.42K
Net Income (ttm)-4.96M
Shares Outn/a
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume5
Open0.3575
Previous Close0.3535
Day's Range0.3575 - 0.3575
52-Week Range0.1570 - 0.4050
Betan/a
RSI62.55
Earnings DateFeb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2009
Employees 9
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8NN
Full Company Profile

Financial Performance

Financial numbers in NOK Financial Statements

News

There is no news available yet.